Sam Palmatier, Pharmacy Intern and Jeff Engle, PharmD, MS, Oncology Pharmacy Manager at Fairview Cancer Clinic – Edina write about
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Mosunetuzumab
December 22, 2022
Bernard Marini, PharmD, BCOP Clinical Pharmacist Specialist – Hematology/Oncology Clinical Associate Professor University of Michigan College of Pharmacy writes about Mosunetuzumab.
Drug Updates
Pharmacist's Application to Practice: Nadofaragene firadenovec-vncg
December 16, 2022
Kelli Rourke, PharmD Clinical Pharmacy Specialist at The Johns Hopkins Hospital writes about nadofaragene firadenovec-vncg
Drug Updates
Pharmacist’s Application to Practice: Mirvetuximab soravtansine-gynx
November 14, 2022
Shrina Patel, PharmD, BCOP, Clinical Pharmacy Specialist at University of Texas MD Anderson Cancer Center writes about Mirvetuximab soravtansine-gynx.
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Tremelimumab
November 10, 2022
Tremelimumab (IMJUDO, AztraZeneca Pharmaceuticals) approved November 10, 2022 for metastatic non-small cell lung cancer and approved October 24, 2022 for unresectable hepatocellular carcinoma
Tools and Resources
Drug Updates
Pharmacist’s Application to Practice: Teclistamab-cqyv
October 25, 2022
Gavyn Walsh, PD3 Oncology Pharmacy Intern and Erin Kelley, PharmD, BCOP at M Health Fairview Masonic Cancer Clinic write about teclistamab-cqyv
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Futibatinib
September 30, 2022
Mei Ka Fong, Pharm.D., BCOP Clinical Pharmacist Coordinator Levine Cancer Institute, Atrium Health writes about Futibatinib
Clear filter
